{
 "PrintNo":"S1720","Session":2023,"Chamber":"SENATE","BillType":"Senate","Published":"2023-01-13T13:51:35.997554Z",
 "Status":"IN_SENATE_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2024-01-03","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2023-01-13","Chamber":"SENATE"},
  {"Text":"REFERRED TO HEALTH","Date":"2024-01-03","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":1232,"Name":"James Skoufis","Short":"SKOUFIS"}],
 "Title":"Adds tianeptine sodium to the list of Schedule II of controlled substances",
 "Summary":"Adds tianeptine sodium to list of Schedule II of controlled substances.","LawSection":"Public Health Law",
 "LawCode":"Amd ยง3306, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to adding tianeptine sodium to schedule II of controlled substances",
 "SameAsPrintNo":"A9188-2023","PreviousVersions":["S8023-2019","S1776-2021"]
}